JenaValve Reports Significant Clinical Milestone: First-ever Successful Transcatheter Implantation of a 27mm Transapical Aortic Valve Prosthesis

WILMINGTON, Del. & MUNICH--(BUSINESS WIRE)--JenaValve™ Technology, Inc., a medical device company specializing in developing transcatheter aortic valve implantation (TAVI) systems, announced today a significant clinical milestone: the first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis.
MORE ON THIS TOPIC